These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 6193874)
1. Plasminogen activator secretion of human tumors in short-term organ culture, including a comparison of primary and metastatic colon tumors. Markus G; Camiolo SM; Kohga S; Madeja JM; Mittelman A Cancer Res; 1983 Nov; 43(11):5517-25. PubMed ID: 6193874 [TBL] [Abstract][Full Text] [Related]
2. Plasminogen activators in human malignant melanoma. Markus G; Kohga S; Camiolo SM; Madeja JM; Ambrus JL; Karakousis C J Natl Cancer Inst; 1984 Jun; 72(6):1213-22. PubMed ID: 6374238 [TBL] [Abstract][Full Text] [Related]
3. Plasminogen activator content and secretion in explants of neoplastic and benign human prostate tissues. Camiolo SM; Markus G; Englander LS; Siuta MR; Hobika GH; Kohga S Cancer Res; 1984 Jan; 44(1):311-8. PubMed ID: 6197164 [TBL] [Abstract][Full Text] [Related]
4. Localization of plasminogen activators in human colon cancer by immunoperoxidase staining. Kohga S; Harvey SR; Weaver RM; Markus G Cancer Res; 1985 Apr; 45(4):1787-96. PubMed ID: 3884145 [TBL] [Abstract][Full Text] [Related]
5. Plasminogen activator content of human colon tumors and normal mucosae: separation of enzymes and partial purification. Corasanti JG; Celik C; Camiolo SM; Mittelman A; Evers JL; Barbasch A; Hobika GH; Markus G J Natl Cancer Inst; 1980 Aug; 65(2):345-51. PubMed ID: 6931252 [TBL] [Abstract][Full Text] [Related]
6. Laminin-5 is a marker of invading cancer cells in some human carcinomas and is coexpressed with the receptor for urokinase plasminogen activator in budding cancer cells in colon adenocarcinomas. Pyke C; Salo S; Ralfkiaer E; Rømer J; Danø K; Tryggvason K Cancer Res; 1995 Sep; 55(18):4132-9. PubMed ID: 7664291 [TBL] [Abstract][Full Text] [Related]
7. Secretion of plasminogen activators by human colorectal and gastric tumor explants. Harvey SR; Lawrence DD; Madeja JM; Abbey SJ; Markus G Clin Exp Metastasis; 1988; 6(6):431-50. PubMed ID: 3409559 [TBL] [Abstract][Full Text] [Related]
8. Plasminogen activator activities in short-term tissue cultures of benign prostatic hyperplasia and prostatic carcinoma. Festuccia C; Vincentini C; di Pasquale AB; Aceto G; Zazzeroni F; Miano L; Bologna M Oncol Res; 1995; 7(3-4):131-8. PubMed ID: 8555646 [TBL] [Abstract][Full Text] [Related]
9. Molecular species of plasminogen activators secreted by normal and neoplastic human cells. Wilson EL; Becker ML; Hoal EG; Dowdle EB Cancer Res; 1980 Mar; 40(3):933-8. PubMed ID: 7193517 [TBL] [Abstract][Full Text] [Related]
10. Content and characterization of plasminogen activators in human lung tumors and normal lung tissue. Markus G; Takita H; Camiolo SM; Corasanti JG; Evers JL; Hobika GH Cancer Res; 1980 Mar; 40(3):841-8. PubMed ID: 7193515 [TBL] [Abstract][Full Text] [Related]
11. Secretion of proteinases from malignant and nonmalignant human breast tissue. Recklies AD; Tiltman KJ; Stoker TA; Poole AR Cancer Res; 1980 Mar; 40(3):550-6. PubMed ID: 6258782 [TBL] [Abstract][Full Text] [Related]
12. Hormonal modulation of plasminogen activator: an approach to prediction of human breast tumor responsiveness. Mira-y-Lopez R; Ossowski L Cancer Res; 1987 Jul; 47(13):3558-64. PubMed ID: 3107811 [TBL] [Abstract][Full Text] [Related]
13. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma. Festuccia C; Teti A; Bianco P; Guerra F; Vicentini C; Tennina R; Villanova I; Sciortino G; Bologna M Oncol Res; 1997; 9(8):419-31. PubMed ID: 9436195 [TBL] [Abstract][Full Text] [Related]
14. Metastasis of human colon tumor cells in vivo: correlation with the overexpression of plasminogen activators and 72 kDa gelatinase. Shah V; Kumar S; Zirvi KA In Vivo; 1994; 8(3):321-6. PubMed ID: 7803712 [TBL] [Abstract][Full Text] [Related]
15. Urokinase plasminogen activator and urokinase plasminogen activator receptor mediate human stem cell tropism to malignant solid tumors. Gutova M; Najbauer J; Frank RT; Kendall SE; Gevorgyan A; Metz MZ; Guevorkian M; Edmiston M; Zhao D; Glackin CA; Kim SU; Aboody KS Stem Cells; 2008 Jun; 26(6):1406-13. PubMed ID: 18403751 [TBL] [Abstract][Full Text] [Related]
16. Identification of markers of possible prognostic value in 57 giant cell tumors of bone. Gamberi G; Serra M; Ragazzini P; Magagnoli G; Pazzaglia L; Ponticelli F; Ferrari C; Zanasi M; Bertoni F; Picci P; Benassi MS Oncol Rep; 2003; 10(2):351-6. PubMed ID: 12579271 [TBL] [Abstract][Full Text] [Related]
17. Expression of the plasminogen activation system in kidney cancer correlates with its aggressive phenotype. Swiercz R; Wolfe JD; Zaher A; Jankun J Clin Cancer Res; 1998 Apr; 4(4):869-77. PubMed ID: 9563880 [TBL] [Abstract][Full Text] [Related]
18. Both the cytosols and detergent extracts of breast cancer tissues are suited to evaluate the prognostic impact of the urokinase-type plasminogen activator and its inhibitor, plasminogen activator inhibitor type 1. Jänicke F; Pache L; Schmitt M; Ulm K; Thomssen C; Prechtl A; Graeff H Cancer Res; 1994 May; 54(10):2527-30. PubMed ID: 8168072 [TBL] [Abstract][Full Text] [Related]
19. Proteolytic enzymes in tumor metastasis. I. Plasminogen activator in clones of Lewis lung carcinoma and T10 sarcoma. Eisenbach L; Segal S; Feldman M J Natl Cancer Inst; 1985 Jan; 74(1):77-85. PubMed ID: 3855489 [TBL] [Abstract][Full Text] [Related]
20. Prognostic role of urokinase-type plasminogen activator in human gliomas. Hsu DW; Efird JT; Hedley-Whyte ET Am J Pathol; 1995 Jul; 147(1):114-23. PubMed ID: 7604873 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]